➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Medtronic
Colorcon
McKinsey
Express Scripts

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Drugs with Dosage: TABLET

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drugs with Dosage: TABLET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Mankind Pharma ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 213614-001 Sep 9, 2020 AB RX No No   Start Trial   Start Trial   Start Trial TABLET;ORAL
Mankind Pharma ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 213614-002 Sep 9, 2020 AB RX No No   Start Trial   Start Trial   Start Trial TABLET;ORAL
Xiromed VOLNEA desogestrel; ethinyl estradiol TABLET;ORAL-28 202689-001 Sep 9, 2016 AB RX No No   Start Trial   Start Trial   Start Trial TABLET;ORAL-28
Mylan Labs Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 202132-001 Sep 9, 2015 DISCN No No   Start Trial   Start Trial   Start Trial TABLET;ORAL-28
Sciegen Pharms Inc LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 203646-001 Sep 9, 2014 AB RX No No   Start Trial   Start Trial   Start Trial TABLET;ORAL
Sun Pharm LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 203059-001 Sep 9, 2013 AB RX No No   Start Trial   Start Trial   Start Trial TABLET, EXTENDED RELEASE;ORAL
Sun Pharm LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 203059-002 Sep 9, 2013 AB RX No No   Start Trial   Start Trial   Start Trial TABLET, EXTENDED RELEASE;ORAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
AstraZeneca
Harvard Business School
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.